Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Kiora Pharmaceuticals, Inc. (KPRX) had Normalized Pre-Tax Income of $-2.08M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.08M |
|
-- |
|
-- |
|
$2.21M |
|
$-2.21M |
|
$0.13M |
|
$-2.08M |
|
|
Normalized Pre-Tax Income |
$-2.08M |
$-2.08M |
|
$-2.08M |
|
$-2.08M |
|
$-2.08M |
|
$-2.21M |
|
$-2.20M |
|
6.18M |
|
6.18M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$21.26M |
|
$0.10M |
|
$2.51M |
|
$23.78M |
|
$2.37M |
|
-- |
|
$4.55M |
|
$6.92M |
|
$16.86M |
|
$14.79M |
|
$16.86M |
|
4.43M |
|
| Cash Flow Statement Financials | |
$-5.05M |
|
$-1.49M |
|
$4.92M |
|
$8.70M |
|
$7.08M |
|
$-1.62M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.33% |
|
-14.05% |
|
-8.74% |
|
-12.33% |
|
$3.81 |
|
$-0.82 |
|
$-0.82 |
|